September 13 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said that the chairman of its board of directors - Ognyan Donev, has acquired 500 shares in the company at a weighed average price per share of 6.45 levs ($3.66/3.30 euro).
Donev acquired the shares on the floor of the Bulgarian Stock Exchange on September 11, Sopharma Trading said in a bourse filing on Thursday.
Donev is also the CEO of Sopharma Trading's majority owner - drug maker Sopharma [BUL:3JR].
Also on September 11, Sopharma acquired 3,000 shares in Sopharma Trading at a weighed average price per share of 6.45 levs.
As at 9:25 CET on Friday, Sopharma Trading shares traded 1.55% lower at 6.35 levs on the Bulgarian Stock Exchange.
At the end of June, Sopharma held a 72.97% stake in Sopharma Trading, while Donev held directly a stake of under 5%.
(1 euro = 1.95583 levs)